Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06580561 · ClinicalTrials.gov registry record · NA

Move and Snooze: Adding Insomnia Treatment to an Exercise Program to Improve Pain Outcomes in Older Adults With Knee Osteoarthritis

A NA study of Insomnia and Knee Osteoarthritis, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
288
Enrollment target
1
Study location

NCT06580561: Recruiting NA study of Insomnia and Knee Osteoarthritis, sponsored by University of Michigan.

NCT06580561 is a NA study of Insomnia and Knee Osteoarthritis that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 288 participants, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06580561, a NA study of Insomnia and Knee Osteoarthritis, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
288 participants
Enrollment target
1
Study location

Study Summary

This research will compare the effectiveness of a remotely delivered personalized exercise coaching plus an evidence-based sleep improvement intervention to remotely delivered personalized exercise coaching alone for knee osteoarthritis pain. The study team hypothesize that the combined intervention will result in greater improvements in patient-reported pain intensity, recorded with real-time data capture, than remotely delivered exercise coaching alone.

Primary Outcome

This is a one question numerical rating scale in which participants select from 0 (no pain) -10 (worst pain imaginable) numerical rating scale 4 times a day over 7 days during each assessment period (baseline and 8-week follow-up). These four within-day ratings collected over seven days will be averaged for each participant to provide a single pain intensity rating for each assessment period.

Interventions

  • BEHAVIORAL Personalized exercise coaching
  • BEHAVIORAL Cognitive behavioral therapy for Insomnia

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2024-11-04
Est. Completion 2028-08-31
Phase NA
University of Michigan

1,327 total trials

What NCT06580561 shows while recruiting

NCT06580561 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (71% higher).

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Personalized exercise coaching is the first listed.

NCT06580561 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06580561 about?

NCT06580561 is a clinical study titled "Move and Snooze: Adding Insomnia Treatment to an Exercise Program to Improve Pain Outcomes in Older Adults With Knee Osteoarthritis". This research will compare the effectiveness of a remotely delivered personalized exercise coaching plus an evidence-based sleep improvement intervention to remotely delivered personalized exercise coaching alone for knee osteoarthritis pain. The study team hypothesize that the combined interventio...

What is the current status of trial NCT06580561?

This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2024-11-04. Estimated completion is 2028-08-31.

What conditions does trial NCT06580561 study?

This clinical trial studies the following conditions: Insomnia, Knee Osteoarthritis.

What interventions are being tested in trial NCT06580561?

The interventions under investigation include: Personalized exercise coaching (BEHAVIORAL), Cognitive behavioral therapy for Insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT06580561?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06580561 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06580561's enrollment target sits among peer trials

288 26th of 151 higher than 126 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT04621877 · 288 participants · NA

    Lay-Delivered Behavioral Activation in Senior Centers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06580561, the US trial registry maintained by the National Library of Medicine. NCT06580561 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.